lung transplant recipient
Showing 1 - 3 of 3
Lung Transplant Recipient, SARS-CoV-2, Immunosuppression Trial (mRNA-1273 (Moderna COVID-19 vaccine))
Active, not recruiting
- Lung Transplant Recipient
- +2 more
- mRNA-1273 (Moderna COVID-19 vaccine)
-
Los Angeles, CaliforniaUCLA Clinical Translational Research Center
Dec 13, 2022
Lung Transplant Recipient, Donor Specific Antibodies, Antibody Mediated Rejection Trial in France (bronchoscopy.)
Recruiting
- Lung Transplant Recipient
- +2 more
- bronchoscopy.
-
Le Plessis Robinson, France
- +4 more
Feb 11, 2022
Lung Transplant Recipient Trial in Toronto (Ambisome ®, Regular standard of care medication)
Suspended
- Lung Transplant Recipient
- Ambisome ®
- Regular standard of care medication
-
Toronto, Ontario, CanadaUniversity Health Network/ Toronto General Hospital
Oct 18, 2011